Bupropion Tablets and Sustained-Release Tablets and Ranibizumab
Determining the interaction of Bupropion Tablets and Sustained-Release Tablets and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupropion
Brand name: Aplenzin, Buproban, Forfivo XL, Wellbutrin SR, Wellbutrin XL, Zyban, Zyban Advantage Pack, Budeprion XL
Synonyms: Bupropion, BuPROPion
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupropion Tablets and Sustained-Release Tablets-Ranibizumab Intraocular
- Bupropion Tablets and Sustained-Release Tablets-Ranibizumab ophthalmic
- Bupropion Tablets and Sustained-Release Tablets-Ranitidine
- Bupropion Tablets and Sustained-Release Tablets-Ranitidine Capsule
- Bupropion Tablets and Sustained-Release Tablets-Ranitidine Hydrochloride
- Bupropion Tablets and Sustained-Release Tablets-Ranitidine Injection
- Ranibizumab-Burapren Injection
- Ranibizumab-Burn-O-Jel Topical application
- Ranibizumab-Burnamycin Topical application
- Ranibizumab-Burosumab
- Ranibizumab-Burosumab-twza
- Ranibizumab-Burosumab-twza Subcutaneous